Medizone International, Inc. Management
Edwin G. Marshall - Chairman of the Board and Chief Executive Officer
Edwin G. Marshall became Chairman of the Board in June, 1997, following a successful hostile proxy takeover. He was additionally appointed Chief Executive Officer in April 1998.
Mr. Marshall attended the College of Marin, with a double major in business and fire science. From 1964 to 1978, Mr. Marshall worked in the fire service in a city with a major chemical industrial complex, leaving with the rank of Captain. He then pursued various business interests including ownership of a real estate brokerage firm and part-ownership of a number of other small businesses in other fields. He has been a private investor in real estate, precious metals, and stocks since 1973.
Dr. Shannon received his medical degree from Queen’s University in Canada, which included advanced training in surgery and sports medicine. He also holds post-graduate degrees in neurochemistry and physiology. He has been actively engaged in applied medical research within these areas for over 27 years.
He served in the Canadian Forces for 31 years retiring at the rank of Commodore (Brigadier General equivalent) as Deputy Surgeon General for Canada. During the first Gulf War, Dr. Shannon served as the senior medical liaison officer for all of the Canadian forces.
In 1996 he assumed responsibilities within Health Canada for re-organizing the Canadian blood system. Working with both the provincial and federal governments he oversaw the development of a new corporate entity dedicated exclusively to the management of blood services in Canada. He was then appointed Director General for the Laboratory Centre for Disease Control, a position he held for three years.
In December 2000, Dr. Shannon left the Canadian federal government to pursue a new career in industry. In that capacity he simultaneously directed a phase III clinical trial in Canada, the United States and Great Britain for an artificial blood substitute product. Following completion of that work he was asked to accept a special assignment with the Canadian Federal Government Auditor General’s office. His assignment being to conduct a cost benefit analysis of all government sponsored pharmacare programs and make recommendations directly to the Parliament of Canada. His assignment and presentation to Parliament was completed in November 2004.
Dr. Shannon then served on a special assignment to the Canadian Public Health Agency (Center for Disease Control equivalent in the United States) as Senior Medical Advisor. His responsibility was to direct the rebuilding of the Emergency Medical Response Capacity for Canada. In this regard and under his direction, the largest emergency medical response exercise in the history of the country, involving the overnight construction of a mobile hospital, hundreds of doctors and thousands of patients, was successfully held in Toronto in December of 2007.
Dr. Shannon has been actively engaged in medical bio-oxidative (O3 based), research since 1987 and was directly responsible for the first human clinical trial to have ever been approved in North America which examined the efficacy of O3 delivered via minor autohemotherapy in the treatment of AIDS. He was also responsible for several primate studies utilizing O3 involving scientists from various departments within the Canadian Federal Government, as well as senior investigators from Medizone International and Cornell University.
Dr. Shannon has served as the Senior Medical Advisor to Medizone International since 2002. In August of 2008 he accepted a position on the Board of Directors of Medizone International and assumed responsibility for medical affairs. In October 2008, he was additionally appointed the President of the Canadian Foundation for Global Health.
Richard Garret Solomon – Director and Executive Officer
Mr. Solomon first invested in Medizone in 1992. In 1995, Medizone New Zealand Limited (a partially owned subsidiary of Medizone International) was formed as a 50/50 joint venture.
In January 1996, until February 1997, Mr. Solomon was a Director of Medizone International, Inc. and has rejoined the board as of May 1, 2000.
Mr. Solomon received a Bachelor of Commerce (University of Otago), Diploma of Business and Industrial Administration (University of Auckland), and is an Associate Chartered Accountant.
His career has been in business and investment, and for 20 years he developed and ran his own private hospital operating company, Haven Care Hospitals Limited. He was a longstanding Board member and President of the New Zealand Hospitals Association. He lead the establishment of The New Zealand Council of Healthcare Standards, Inc.
Mr. Hoyt became a director in January 2002. Mr. Hoyt is a graduate of the University of Indiana, where he received a Bachelor of Science degree in Business Administration. Over the past 37 years, he has become a recognized leader in the life insurance industry, working as a career agent for American United Life Insurance Company. Mr. Hoyt’s clients have ranged from large public companies to small private businesses.
In recent years he has spent most of his time in public speaking and relationship building in the insurance industry. His previous work experience includes seven years with Merrill Lynch as well as serving as the Chief Executive for the Chamber of Commerce in three Indiana communities.
From June 1996 until June 2010, Mr. Hoyt was the Chairman of the Board of Biological Systems, Inc., a privately held corporation involved with bio-cleansing remediation systems for animal fats and oil-based materials. He also serves on the Development Board of the Indiana University Simon Cancer Center (since January 2000) and is the Chairman of the Board of the St. Vincent Foundation in Indianapolis, Indiana.
Tommy Auger has over 17 years of financial accounting, operational and management experience with growth businesses.
He has worked in public accounting at the international firms of Deloitte, Andersen and KPMG where he provided businesses with accounting, financial statement audit and business consulting services. He has also gained significant experience working with SEC registrants and required filings, including IPO and mergers and acquisitions.
Mr Auger’s career has seen him service mid to large-sized public and private companies in the bio-technology, real estate, hospitality and entertainment, high-technology, trucking and professional service industries.
Tommy graduated from Oklahoma City University with a Master’s of Science in Accounting and is a Certified Public Accountant (CPA). He is currently actively involved in the Utah Association of Certified Public Accounting (UACPA) and was instrumental in developing the Pronet Council, which helps accounting students throughout Utah.
The UACPA and other volunteer church and civic organizations often call upon Tommy for “guest speaking” roles.
Outside of work, he loves spending time with his wife and children. He also enjoys participating in and/or watching sporting events.